FDA Science Board recommends creation of centralized new alternative methods office
Regulatory NewsFerdous Al-Faruque
Advisory committeesDiagnostics/IVDsMedical DevicesPharmaceuticalsPreclinicalRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)